Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

Thus, candidates should be tested against a panel of receptors at the time of antibody engineering. ACROBiosystems provides an extensive collection of recombinant Fc receptor proteins, which ...

antibody. CF patients, chronic pulmonary disease patients and hypogammaglobulinemics had accelerated Fc receptor mediated clearance rates (T 1/2 =19.6 min, 16 min and 12.8 min, respectively ...

Phase III Vivacity-MG3 trial shows that nipocalimab, an investigational FcRn blocker, significantly the improves symptoms of generalized myasthenia gravis with a manageable safety profile.

Activating FcR with subthreshold levels of the IgG antibody on cancer cells also primed the macrophages for their next meal.